Back

Atrial natriuretic peptide hypersecretion contributes to systemic insulin resistance in pressure overload heart failure

28 May 2018 (10:54 - 11:00)
Organised by:
Congress Presentation Part of: Moderated Poster session 4 - Basic Science Experimental Heart Failure HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Feng Gao

Fourth Military Medical University, Xi'an (China)

9 More presentations in this session

Presentation thumbnail
Alpha1-adrenergic receptor agonists activate Akt signalling via insulin family receptors
Doctor D. Meijles (London, GB)
Abstract
Presentation thumbnail
Kruppel-like factors regulation in a zebrafish heart failure model
Mr A. Lumley (Luxembourg, LU)
Abstract
Presentation thumbnail
Improved diastolic stiffness through restored endothelial function and titin phosphorylation with chronic stimulation of soluble guanylyl cyclase in heart failure with preserved ejection fraction
Doctor A. Kovacs (Debrecen, HU)
Abstract
Presentation thumbnail
A comparative study of LCZ696, valsartan and resveratrol for the treatment of acute cardiac remodeling and dysfunction in myocardial infarction induced rats
Mr P. Raj (Manitoba, CA)
Abstract
Presentation thumbnail
Omecamtive mecarbil causes alternating excitation-contraction coupling at high pacing frequencies
Doctor B. Horvath (Debrecen, HU)
Abstract

Access the full session

Session thumbnail
Moderated Poster session 4 - Basic Science

The Event

Event poster

Heart Failure 2018

28 May 2018 10:54 CET
You may be interested in
thumbnail
Webinar
GLP-1 RAs and HFpEF: which HFpEF patients should now be receiving GLP-1 RAs?
15 December 2025
thumbnail
Congress Presentation
Pressure overload and volume overload-induced chronic heart failure are associated with unique myocardial microRNA expression patterns
29 June 2021
thumbnail
Webinar
Natriuretic peptides: role for risk prediction and treatment efficacy
7 October 2021
thumbnail
Congress Presentation
Insulin resistance indices are associated with the presence and outcomes of pulmonary hypertension due to left heart failure
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources